Form 8-K - Current report:
SEC Accession No. 0001564590-21-032698
Filing Date
2021-06-14
Accepted
2021-06-14 08:00:22
Documents
14
Period of Report
2021-06-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prtk-8k_20210609.htm   iXBRL 8-K 64954
2 EX-99.1 prtk-ex991_6.htm EX-99.1 16198
3 GRAPHIC g4ybzpwe3uo4000001.jpg GRAPHIC 13217
  Complete submission text file 0001564590-21-032698.txt   234075

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA prtk-20210609.xsd EX-101.SCH 5780
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE prtk-20210609_lab.xml EX-101.LAB 18717
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prtk-20210609_pre.xml EX-101.PRE 11176
7 EXTRACTED XBRL INSTANCE DOCUMENT prtk-8k_20210609_htm.xml XML 3419
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36066 | Film No.: 211013334
SIC: 2834 Pharmaceutical Preparations